Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Dockendorff Charles J, Director. Director active across 5 companies, notably Boston Scientific CORP. In total, 26 reports have been published. Breakdown: 1 buy · 3 sells. Total volume traded: €1.9m. History available since 6 May 2021. The latest transaction was filed on 21 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Charles J. Dockendorff serves as a Board Member at Boston Scientific Corp and Haemonetics Corp. He is involved in the governance and strategy of these companies. Charles brings a unique perspective through his diverse experience, contributing to informed decision-making within the boards.